News
National Cancer Treatment Alliance 2023/2024 Public Benefit Report
Pursuant to the charter of the National Cancer Treatment Alliance (NCTA), and in accordance with applicable state laws, we present the 2023/2024 NCTA Public Benefit Report. This report seeks to capture our promotion of the public benefit specified in the NCTA charter and the interests of those affected by our activities.
Best Practices When Choosing Tissue or Liquid Biopsy Specimens For Biomarker Testing in Non-Small Cell Lung Cancer (NSCLC)
Register and Save the Date for June 17, 2025, 2:00 PM. This 30-minute educational webinar is designed for clinicians and other providers seeking to optimize biomarker testing strategies in non-small cell lung cancer (NSCLC). The session provides a comprehensive overview of when and how to utilize tissue and liquid biopsy specimens across the NSCLC care continuum.
National Cancer Treatment Alliance Partners with XO Health to Offer Employers Direct Contracting Opportunities in Oncology
The National Cancer Treatment Alliance (NCTA), a national network of independent community oncology practices working to increase access to high-quality and local cancer care, announced today that it has partnered with XO Health to provide employers access to NCTA’s high-performing, high-value oncology network for their employees.
National Cancer Treatment Alliance Adds Kiana Mehring, MBA, as Board Member
The National Cancer Treatment Alliance (NCTA), a national network of independent community oncology practices that works with employers to ensure their employees have access to high-quality, high-value, and local cancer care, announced today that Kiana Mehring, MBA, of Florida Cancer Specialists and Research Institute (FCS), has joined the NCTA Board of Directors.
Biomarker Testing: What Employers and Insurers Need to Know
The National Cancer Treatment Alliance (NCTA) held a webinar on Tuesday, August 27, at 1 p.m. ET for an overview of biomarker testing, the benefits of providing it for employees, and solutions to common barriers when making these resources available.
National Cancer Treatment Alliance Expands Geographic Footprint with Five New Member Practices
The National Cancer Treatment Alliance (NCTA) announced today five new member practices. NCTA now has 50 practices with 248 locations across 30 states.
National Cancer Treatment Alliance Appoints Two New Board Members
The National Cancer Treatment Alliance (NCTA), a nationwide network of leading, independent community oncology practices that have joined together to help employers improve cancer care, announced today the appointment of two new board members, Mark Nelson, PharmD, Chief Executive Officer at Northwest Medical Specialties and Travis Brewer, Vice President of Payer and Public Health Strategy/Relations at Texas Oncology.
National Cancer Treatment Alliance Announces 43 Oncology Practices As Inaugural Members
The National Cancer Treatment Alliance (NCTA) announced today the launch of a nationwide, clinically integrated network (CIN) of leading community oncology practices and pharmacies. Joining the CIN are 43 practices across 24 states. The organization seeks to partner with employers to reduce costs and ensure high-quality, patient-centered cancer care.